The Moret Group since Dec 2012
Assistant Designer
Carole Hochman Design Group - New York, NY Oct 2011 - Nov 2012
Assistant Designer for Lauren Ralph Lauren
Julia B. - New York, NY Jan 2011 - Sep 2011
Freelance Assistant Designer
Komar Sleepwear May 2010 - Jan 2011
Design Intern
Vandale Industries May 2010 - Aug 2010
Design Intern
Education:
Fashion Institute of Technology 2008 - 2011
Fashion Design, Intimate Apparel, Women's Sportswear
Polimoda 2007 - 2008
Stephens College 2006 - 2007
North High School
Featured in Washington Post's "Highlights of Mercedes-Benz Fashion Week"
Finalist in Supima Cotton Design Competition
1st Place Femmy Gala Student Design Competition,
1st place Lululemon Urban Yogini Design Competition, Concept board winner- Project OR Design Competition,
Critic Award Winner- FIT AAS Design Exhibit
John E. Stelmach - Westfield NJ, US Emma R. Parmee - Scotch Plains NJ, US James R. Tata - Westfield NJ, US Keith G. Rosauer - Laurence Harbor NJ, US Ronald M. Kim - Summit NJ, US Amy R. Bittner - Scotch Plains NJ, US Jiang Chang - Westfield NJ, US Christopher Joseph Sinz - Cranford NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/404 C07D 209/14
US Classification:
514415, 548511
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
John E. Stelmach - Westfield NJ, US Emma R. Parmee - Scotch Plains NJ, US James R. Tata - Westfield NJ, US Keith G. Rosauer - Laurence Harbor NJ, US Ronald M. Kim - Summit NJ, US Amy R. Bittner - Scotch Plains NJ, US Jiang Chang - Westfield NJ, US Christopher Joseph Sinz - Cranford NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/404 C07D 209/10
US Classification:
514415, 548511
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Amy R. Bittner - Westfield NJ, US Ronald M. Kim - Summit NJ, US John W. Mirc - Tokyo, JP Emma R. Parmee - Doylestown PA, US Christopher Joseph Sinz - Middletown NJ, US Qiang Tan - Westfield NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 345/00 C07D 517/00 C07D 413/00 C07D 401/00
US Classification:
540 1, 5462691, 5462754
Abstract:
A compound having the structure.
Acyl Indoles, Compositions Containing Such Compounds And Methods Of Use
Ronald Kim - Summit NJ, US Amy Bittner - Scotch Plains NJ, US Christopher Sinz - Cranford NJ, US Emma Parmee - Scotch Plains NJ, US
International Classification:
C07D 209/42 A61K 31/405
US Classification:
514415000, 548492000
Abstract:
The present invention relates to substituted indoles, compositions containing such compounds and methods of treatment The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus and related conditions.
Amy R. Bittner - Princeton NJ, US Christopher Joseph Sinz - Cranford NJ, US Jiang Chang - Westfield NJ, US Ronald M. Kim - Summit NJ, US J. W. Mirc - Union City NJ, US Emma R. Parmee - Schotch Plains NJ, US Qiang Tan - Westfield NJ, US
A compound having the structureuseful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, angina pectoris, thromboses, restenoses, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver in a human or animal patient.
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
John E. Stelmach - Westfield NJ, US Emma R. Parmee - Scotch Plains NJ, US James R. Tata - Westfield NJ, US Keith G. Rosauer - Laurence Harbor NJ, US Ronald M. Kim - Summit NJ, US Amy R. Bittner - Scotch Plains NJ, US Jiang Chang - Westfield NJ, US Christopher Joseph Sinz - Cranford NJ, US
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. (I)
Center Grove Elementary School Randolph NJ 1987-1994, Randolph Middle School Randolph NJ 1994-1996
Community:
Renee Parzero, Kevin Murphy, Cindy Isaza, Doug Norman, Joseph Delloiacovo, Laura Szypiotko, John Dellarusso, Thomas Tertis, Cristina Capsouras, John Bell, Nicole Kimble